tiprankstipranks
Advertisement
Advertisement
GT Biopharma price target lowered to $3 from $8 at Roth Capital
PremiumThe FlyGT Biopharma price target lowered to $3 from $8 at Roth Capital
3M ago
GT Biopharma price target lowered to $3 from $8 at Roth Capital
Premium
The Fly
GT Biopharma price target lowered to $3 from $8 at Roth Capital
3M ago
GT Biopharma expects cash to fund operations through Q4 2026
Premium
The Fly
GT Biopharma expects cash to fund operations through Q4 2026
3M ago
GTBP Upcoming Earnings Report: What to Expect?
PremiumPre-EarningsGTBP Upcoming Earnings Report: What to Expect?
7M ago
GT Biopharma files to sell 14.59M shares of common stock for holders
Premium
The Fly
GT Biopharma files to sell 14.59M shares of common stock for holders
7M ago
GT Biopharma provides enrollment update on GTB-3650 Phase 1 Trial
Premium
The Fly
GT Biopharma provides enrollment update on GTB-3650 Phase 1 Trial
8M ago
GT Biopharma advances into cohort 3 of GTB-3650 Phase 1 trial
PremiumThe FlyGT Biopharma advances into cohort 3 of GTB-3650 Phase 1 trial
10M ago
GT Biopharma Approves Key Proposals at Annual Meeting
Premium
Company Announcements
GT Biopharma Approves Key Proposals at Annual Meeting
10M ago
GT Biopharma appoints Mun-Gavin to board of directors
Premium
The Fly
GT Biopharma appoints Mun-Gavin to board of directors
12M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100